Given the pivotal role of the IL-6/STAT3 axis in promoting tumor growth, survival, and inflammatory signaling, this robust inhibition indicates that KAE exerts potent anti-inflammatory and anticancer activity, nearly matching the efficacy of the standard chemotherapeutic. This evidence concerns the gene IL6 and neoplasm.